SCHEMBL12632467

SCHEMBL12632467

CC(C)(C)c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
EPHX2 P34913 1/20 0.53
NR1H4 Q96RI1 1/20 0.53
PTGS2 P35354 5/20 0.50
KIF11 P52732 3/20 0.48
FLT3 P36888 1/20 0.47
ENPP2 Q13822 1/20 0.46
TGFBR1 P36897 1/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 1/20 0.46
HSD11B1 P28845 1/20 0.46
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
NPC1 O15118 1/20 0.44
GMNN O75496 1/20 0.44
DRD1 P21728 1/20 0.44
DRD3 P35462 1/20 0.44
CCR2 P41597 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1107981 0.93 ALDH1A1 (0.64) ALDH1A1EPHX2NR1H4PTGS2ENPP2
SCHEMBL15383714 0.84 ALDH1A1 (0.59) ALDH1A1KIF11LMNAGAAHSD11B1
SCHEMBL4490768 0.83 HSD11B1 (0.49) EPHX2NR1H4PTGS2KIF11ENPP2
SCHEMBL10300269 0.83 PTGS2 (0.62) PTGS2KIF11ENPP2
SCHEMBL7677302 0.83 PTGS2 (0.62) PTGS2KIF11ENPP2
SCHEMBL19743211 0.82 KIF11 (0.52) ALDH1A1KIF11LMNAGAAHSD11B1
SCHEMBL12253722 0.81 RXRA (0.57) PTGS2KIF11FLT3CYP2C9HSD17B2
SCHEMBL7506839 0.81 PTGS2 (0.72) PTGS2KIF11
SCHEMBL17897408 0.81 ALDH1A1 (0.55) ALDH1A1KIF11LMNAGAAHSD11B1
SCHEMBL18118194 0.81 CA2 (0.67) ALDH1A1EPHX2NR1H4KIF11NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200277268-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2020-09-03 US disclosed
US-9585891-B2 Alpha hydroxy amides MERCK PATENT GMBH (DE) 2017-03-07 US disclosed
US-9585891-B2 Alpha hydroxy amides MERCK PATENT GMBH (DE) 2017-03-07 US disclosed
US-20150250792-A1 ALPHA HYDROXY AMIDES MERCK PATENT GMBH (DE) 2015-09-10 US disclosed
US-20150250792-A1 ALPHA HYDROXY AMIDES MERCK PATENT GMBH (DE) 2015-09-10 US disclosed
US-7947684-B2 anticoagulants; immunomoderators; antiinflammatory agents AVENTIS PHARMACEUTICALS INC. (US) 2011-05-24 US disclosed
US-20090291945-A1 CYSTEINE PROTEASE INHIBITORS TEIJIN PHARMA LIMITED (JP) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291945-A1 CYSTEINE PROTEASE INHIBITORS CTSE, SPINT2, CTSF ALDH1A1 2506/4885EPHX2 2557/4885NR1H4 2500/4885
US-20200277268-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF MKI67, PKD1, ETV6 ALDH1A1 848/4885EPHX2 2216/4885NR1H4 2010/4885
US-20150250792-A1 ALPHA HYDROXY AMIDES HCAR1, NAA40, HCAR2 ALDH1A1 847/4885EPHX2 402/4885NR1H4 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.